Zions Bancorporation’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $26K | Hold |
63
| – | – | ﹤0.01% | 477 |
|
2024
Q3 | $31.8K | Sell |
63
-433
| -87% | -$219K | ﹤0.01% | 469 |
|
2024
Q2 | $242K | Buy |
496
+31
| +7% | +$15.1K | 0.02% | 306 |
|
2024
Q1 | $251K | Sell |
465
-6
| -1% | -$3.24K | 0.02% | 306 |
|
2023
Q4 | $261K | Sell |
471
-98
| -17% | -$54.4K | 0.02% | 295 |
|
2023
Q3 | $249K | Buy |
569
+91
| +19% | +$39.8K | 0.02% | 289 |
|
2023
Q2 | $240K | Sell |
478
-1
| -0.2% | -$502 | 0.02% | 296 |
|
2023
Q1 | $240K | Sell |
479
-376
| -44% | -$188K | 0.02% | 296 |
|
2022
Q4 | $349K | Buy |
855
+178
| +26% | +$72.6K | 0.03% | 273 |
|
2022
Q3 | $221K | Buy |
677
+129
| +24% | +$42.1K | 0.02% | 297 |
|
2022
Q2 | $192K | Buy |
548
+63
| +13% | +$22.1K | 0.02% | 317 |
|
2022
Q1 | $265K | Buy |
485
+412
| +564% | +$225K | 0.02% | 298 |
|
2021
Q4 | $48K | Buy |
73
+4
| +6% | +$2.63K | ﹤0.01% | 460 |
|
2021
Q3 | $43K | Buy |
69
+49
| +245% | +$30.5K | ﹤0.01% | 469 |
|
2021
Q2 | $13K | Buy |
20
+1
| +5% | +$650 | ﹤0.01% | 671 |
|
2021
Q1 | $9K | Sell |
19
-18
| -49% | -$8.53K | ﹤0.01% | 726 |
|
2020
Q4 | $18K | Buy |
37
+2
| +6% | +$973 | ﹤0.01% | 569 |
|
2020
Q3 | $14K | Hold |
35
| – | – | ﹤0.01% | 600 |
|
2020
Q2 | $12K | Hold |
35
| – | – | ﹤0.01% | 591 |
|
2020
Q1 | $8K | Hold |
35
| – | – | ﹤0.01% | 627 |
|
2019
Q4 | $9K | Hold |
35
| – | – | ﹤0.01% | 737 |
|
2019
Q3 | $10K | Hold |
35
| – | – | ﹤0.01% | 711 |
|
2019
Q2 | $10K | Buy |
35
+3
| +9% | +$857 | ﹤0.01% | 647 |
|
2019
Q1 | $7K | Hold |
32
| – | – | ﹤0.01% | 732 |
|
2018
Q4 | $6K | Buy |
32
+29
| +967% | +$5.44K | ﹤0.01% | 368 |
|
2018
Q3 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 743 |
|
2018
Q2 | – | Sell |
-1,099
| Closed | -$210K | – | 558 |
|
2018
Q1 | $210K | Buy |
1,099
+75
| +7% | +$14.3K | 0.05% | 132 |
|
2017
Q4 | $160K | Sell |
1,024
-16
| -2% | -$2.5K | 0.03% | 182 |
|
2017
Q3 | $162K | Buy |
+1,040
| New | +$162K | 0.02% | 305 |
|